Similar articles

• [Tamoxifen and endometrial adenocarcinoma].

  Rodier JF, Camus E, Janser JC, Renaud R, Rodier D. Rodier JF, et al. Bull Cancer. 1990;77(12):1207-10. Bull Cancer. 1990. PMID: 2081280 Review. French.
• Endometrial carcinoma in five patients with breast cancer on tamoxifen therapy.

  Mathew A, Chabon AB, Kabakow B, Drucker M, Hirschman RJ. Mathew A, et al. N Y State J Med. 1990 Apr;90(4):207-8. N Y State J Med. 1990. PMID: 1692115 No abstract available.
• [Breast cancer, tamoxifen, and uterus].

  Palacios A, Pertusa S, Montoya A, Martínez San Pedro R. Palacios A, et al. Med Clin (Barc). 1993 Mar 27;100(12):479. Med Clin (Barc). 1993. PMID: 8479228 Spanish. No abstract available.
• Tamoxifen associated uterine pathology in breast cancer patients with abnormal bleeding.

  Fotiou S, Tserkezoglou A, Hadjieleftheriou G, Apostolikas N, Karydas I, Stravolemos K. Fotiou S, et al. Anticancer Res. 1998 Jan-Feb;18(1B):625-9. Anticancer Res. 1998. PMID: 9584044
• Endometrial carcinoma following treatment for breast carcinoma in a Nigerian female. A case report and review of the literature.

  Abudu EK, Musa O, Adefuye PO, Abdul Kareem FB, Agboola AO, Banjo AA. Abudu EK, et al. Niger Postgrad Med J. 2007 Dec;14(4):355-7. Niger Postgrad Med J. 2007. PMID: 18163149 Review.